These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 520401)

  • 1. Bioavailability and pharmacokinetics of cimetidine.
    Grahnén A; von Bahr C; Lindström B; Rosén A
    Eur J Clin Pharmacol; 1979 Nov; 16(5):335-40. PubMed ID: 520401
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of cimetidine in man.
    Walkenstein SS; Dubb JW; Randolph WC; Westlake WJ; Stote RM; Intoccia AP
    Gastroenterology; 1978 Feb; 74(2 Pt 2):360-5. PubMed ID: 620910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cimetidine disposition in the aged.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983; 5(4):255-62. PubMed ID: 6888088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function.
    Guay DR; Matzke GR; Bockbrader HN; Dancik J
    Clin Pharm; 1983; 2(2):157-62. PubMed ID: 6883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.
    Larsson R; Erlanson P; Bodemar G; Walan A; Bertler A; Fransson L; Norlander B
    Br J Clin Pharmacol; 1982 Feb; 13(2):163-70. PubMed ID: 7059413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of cimetidine following administration of a single dose by the rapid intravenous route and by the oral route].
    Arancibia A; Schindler I; Paccot E; Ruiz I; Gonzalez G; Mella F; Thambo S
    Therapie; 1985; 40(2):87-92. PubMed ID: 4002195
    [No Abstract]   [Full Text] [Related]  

  • 10. Cimetidine bioavailability after massive small bowel resection.
    Russo J; Watson WA; Nelson EW; Schentag JJ
    Clin Pharm; 1982; 1(6):558-61. PubMed ID: 7185547
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of cimetidine in patients undergoing hemodialysis.
    Bjaeldager PA; Jensen JB; Nielsen LP; Larsen NE; Hvidberg EF
    Nephron; 1983; 34(3):159-63. PubMed ID: 6877447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability study of two tablet formulations of cimetidine.
    Berardi RR; Cohen IA; Hyneck ML; Lockwood GF; Shukla UA; Sakmar E; Wells JJ; Wagner JG
    Biopharm Drug Dispos; 1984; 5(2):169-76. PubMed ID: 6743784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of cimetidine with observations on the plasma concentration-response curve.
    Somogyi A; Gugler R
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():83S-87S. PubMed ID: 7321662
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired cimetidine absorption due to antacids and metoclopramide.
    Gugler R; Brand M; Somogyi A
    Eur J Clin Pharmacol; 1981; 20(3):225-8. PubMed ID: 7286040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine dynamics after single intravenous doses.
    Pancorbo S; Bubrick MP; Chin TW; Miller KW; Onstad G
    Clin Pharmacol Ther; 1982 Jan; 31(1):83-8. PubMed ID: 7053310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of oral cimetidine in chronic renal failure and during haemodialysis.
    Bjaeldager PA; Jensen JB; Larsen NE; Hvidberg EF
    Br J Clin Pharmacol; 1980 Jun; 9(6):585-92. PubMed ID: 7387814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.
    Bodemar G; Norlander B; Fransson L; Walan A
    Br J Clin Pharmacol; 1979 Jan; 7(1):23-31. PubMed ID: 760739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine pharmacokinetics.
    Abate MA; Hyneck ML; Cohen IA; Berardi RR
    Clin Pharm; 1982; 1(3):225-33. PubMed ID: 6764387
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.